On June 25, 2010

J&J’s Other Headache: Foreign Bribery Probe Targets Shanghai Unit

As if Johnson & Johnson (JNJ) didn’t have enough problems with the Tylenol recall, the company’s medical devices unit in Shanghai is being investigated for allegedly paying bribes to Zhang Jingli, a deputy chief of the Chinese state FDA, according


  • By admin  0 Comments 
  • 0 Comments